EDMONTON, ALBERTA--(Marketwire - March 26, 2013) - Canadians with debilitating diseases will soon benefit from new personalized approaches to treatment thanks to researchers across the country and funding from the Harper Government. The Honourable Rona Ambrose, Minister of Public Works and Government Services and Minister for Status of Women, today announced an investment of $2.4 million to support a research project in Alberta, as part of the national announcement made by the Honourable Gary Goodyear, Minister of State (Science and Technology), alongside Mike Lake, Parliamentary Secretary to the Minister of Industry.
"Our government recognizes that genomics is a science at the core of the global bio-economy and offers a myriad of social and economic benefits," said Minister Ambrose. "Through our investments in applied genomics research, we are fostering Canada's innovative capability, while creating jobs and supporting long-term economic growth. These projects have the potential to transform the way health care is delivered in Canada, including improvements in clinical practice, better treatment and outcomes for patients and a more efficient, cost-effective health care system."
The research project is part of a major $150 million genomics and personalized health competition, a Genome Canada-Canadian Institutes of Health Research (CIHR) partnership.
At the University of Alberta, Christopher McCabe will lead a research project entitled PACE-'Omics: Personalized, Accessible, Cost-Effective applications of 'Omics technologies.
Seventeen projects in total have been approved for funding, each valued in the range of $3 million to $13 million. The projects will focus on the application of genomics to tailor patient treatments and therapies in fields as diverse as epilepsy, autism, HIV/AIDS, cancer, cardiovascular disease, rare neurological diseases, and stroke, among others. The projects will be spearheaded by some of Canada's top researchers and leading teams at academic institutions across Canada.
In light of this competition, the Harper Government has invested approximately $45 million through Genome Canada, $24 million through CIHR and $2 million from the Cancer Stem Cell Consortium. The balance of funding is secured by regional Genome Centres from provincial governments, health charities, the private sector and other partners.
"What's exciting about these projects is that each one holds enormous potential for breakthroughs where there is a serious clinical need. Personalized health is about tailoring treatment and medicines to the individual patient based on their unique genetic makeup and this is only possible through advances in genomics research," said Dr. Pierre Meulien, President and CEO of Genome Canada.
"Our partnership with Genome Canada and the Cancer Stem Cell Consortium is providing us with the ability to invest in a fashion that will impact many areas of health such as infection, cancer and rare diseases," said Dr. Alain Beaudet, President of CIHR. The projects announced today have the potential of allowing physicians to make better informed decisions and of providing patients with the best treatments and diagnoses possible."
To build on Genome Canada's achievements to date, Economic Action Plan 2013 proposes to provide $165 million in 2014-15 to support Genome Canada's multi-year strategic plan.
Since 2006, the Harper Government has provided more than $9 billion in new funding for initiatives to support science, technology and the growth of innovative firms, helping to foster a world-class research and innovation system. Economic Action Plan 2013 is proposing to build on this strong foundation, helping to position Canada for sustainable, long-term economic prosperity and a higher quality of life for Canadians.
A complete list of the successful projects is available on Genome Canada's website at www.genomecanada.ca.
This news release is available online at: www.actionplan.gc.ca.